• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Pediatrix Medical Group to Host Premier Neonatology Conference Feb. 19-21

    2/11/25 6:00:00 AM ET
    $MD
    Hospital/Nursing Management
    Health Care
    Get the next $MD alert in real time by email

    As the preterm birth rate remains at an all-time high, continuing education for providers of neonatal intensive care is critical

    Pediatrix® Medical Group, Inc. (NYSE:MD), a leading provider of physician services, is pleased to announce NEO: The Conference for Neonatology, a premier educational event dedicated to advancing the field of neonatology. The conference will be held Feb. 19-21 in Las Vegas, Nevada, and will bring together neonatologists, pediatricians, advanced practitioners and allied health professionals from around the globe.

    As a trusted provider of neonatology services for more than 45 years, Pediatrix cares for nearly a quarter of the infants born in the United States that require intensive care.

    The March of Dimes' 2024 Report Card, released in November, reported that the nation's preterm birth rate remains historically high at 10.4%, with 370,000 babies born prematurely in 2023. In 2022, the rate was 10.5%. The U.S. earned a D+ for the third consecutive year, remaining the worst grade in the report's history.

    "These findings emphasize the need for continuous innovation in the field of neonatal-perinatal medicine," said Timothy Biela, M.D., neonatologist at Pediatrix Neonatology of San Antonio and director of the NEO conference. "We are proud to lead research efforts and provide continuing education opportunities not only for our affiliated clinicians, but for all providers of this highly specialized care. Our hope is to improve outcomes for our youngest and most vulnerable patients."

    About the Conference

    Now in its 46th year, the NEO conference addresses the latest advancements, research and best practices in neonatology. The meeting aims to provide a platform for knowledge exchange, professional development and collaboration among health care professionals dedicated to the care of newborns.

    The comprehensive program includes:

    • Plenary sessions on cutting-edge research and clinical practices
    • Interactive workshops and hands-on training sessions
    • Panel discussions with industry experts and thought leaders
    • Networking opportunities with peers and leaders in neonatology
    • Exhibits showcasing the latest technologies and products in neonatal care

    Keynote Speakers

    The NEO conference will feature an impressive lineup of keynote speakers, including renowned experts in the field of neonatology. Among the distinguished speakers are:

    • Dan Ellsbury, M.D., Director of Quality and Safety for Neonatology, the Pediatrix Center for Research, Education, Quality and Safety (CREQS)
    • Elizabeth Foglia, M.D., MSCE, Associate Professor of Pediatrics, University of Pennsylvania Perelman School of Medicine | Children's Hospital of Philadelphia
    • Haresh Kirpalani, M.D., Professor of Pediatrics, University of Pennsylvania Perelman School of Medicine
    • Josef Neu, M.D., Professor of Pediatrics, University of Florida College of Medicine
    • Noelle Younge, M.D., MHS, Jean and George W. Brumley, Jr., M.D., Assistant Professor of Pediatrics, Duke University School of Medicine
    • Robert Ursprung, M.D., MMSc, Director of Quality and Safety for Neonatology, the Pediatrix CREQS

    These thought leaders will share their insights on groundbreaking research, innovative treatments and emerging trends in neonatal care.

    Legends of Neonatology

    Established in 2007, the Legends of Neonatology award honors remarkable individuals whose clinical contributions have helped forge new ground in neonatal medicine. This year's recipient is David K. Stevenson, M.D., Harold K. Faber Professor of Pediatrics, Senior Associate Dean for Maternal and Child Health at the Stanford University School of Medicine and Principal Investigator of the Prematurity Research Center. Over the span of four decades, Dr. Stevenson has been at the forefront of research, professional education and clinical care in neonatology. He has made pioneering contributions to neonatology and pediatrics through extensive research in bilirubin biochemistry, heme oxygenase biology and neonatal jaundice. His work has led to new technologies and standards of care for the treatment of neonatal jaundice.

    Accredited Continuing Education

    Participants attending the NEO conference will have the opportunity to earn accredited continuing education credits. The Pediatrix CREQS is accredited by:

    • The Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians, designating this live activity for a maximum of 20.25 AMA PRA Category 1 Credits™.
    • The American Nurses Credentialing Center's Commission on Accreditation as a provider of nursing continuing professional development, designating this live activity for a maximum of 20.25 nursing contact hour(s).

    About Pediatrix Medical Group

    Pediatrix® Medical Group, Inc. (NYSE:MD) is a leading provider of physician services. Pediatrix-affiliated clinicians are committed to providing coordinated, compassionate and clinically excellent services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Specialties include obstetrics, maternal-fetal medicine and neonatology. The group's high-quality, evidence-based care is bolstered by significant investments in research, education, quality improvement and safety initiatives. The physician-led company was founded in 1979 as a single neonatology practice and today provides its highly specialized and often critical care services through approximately 4,400 affiliated physicians and other clinicians. To learn more about Pediatrix, visit www.pediatrix.com or follow us on Facebook, Instagram, LinkedIn and the Pediatrix blog. Investment information can be found at www.pediatrix.com/investors.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250211765616/en/

    For media inquiries, please contact:

    Jennifer Gutierrez, Corporate Communications

    [email protected]

    954.384.0175 ext. 5684

    Get the next $MD alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MD

    DatePrice TargetRatingAnalyst
    12/16/2024Outperform
    Macquarie
    9/26/2024$8.00 → $14.00Hold → Buy
    Jefferies
    6/7/2024$8.00Sell → Hold
    Deutsche Bank
    2/23/2022$32.00 → $31.00Outperform
    Credit Suisse
    12/22/2021$33.00 → $32.00Outperform
    Credit Suisse
    11/4/2021$29.00 → $27.00Market Perform
    SVB Leerink
    9/27/2021$29.00Market Perform
    SVB Leerink
    8/9/2021$30.00 → $32.00Neutral
    Mizuho
    More analyst ratings

    $MD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Pediatrix Medical Group Inc.

      SC 13G - Pediatrix Medical Group, Inc. (0000893949) (Subject)

      11/13/24 4:30:24 PM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Pediatrix Medical Group Inc.

      SC 13G/A - Pediatrix Medical Group, Inc. (0000893949) (Subject)

      10/31/24 11:54:57 AM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • SEC Form SC 13G/A filed by Pediatrix Medical Group Inc. (Amendment)

      SC 13G/A - Pediatrix Medical Group, Inc. (0000893949) (Subject)

      6/10/24 12:43:02 PM ET
      $MD
      Hospital/Nursing Management
      Health Care

    $MD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Macquarie initiated coverage on Pediatrix Medical Group

      Macquarie initiated coverage of Pediatrix Medical Group with a rating of Outperform

      12/16/24 7:46:05 AM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • Pediatrix Medical Group upgraded by Jefferies with a new price target

      Jefferies upgraded Pediatrix Medical Group from Hold to Buy and set a new price target of $14.00 from $8.00 previously

      9/26/24 7:37:57 AM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • Pediatrix Medical Group upgraded by Deutsche Bank with a new price target

      Deutsche Bank upgraded Pediatrix Medical Group from Sell to Hold and set a new price target of $8.00

      6/7/24 8:14:20 AM ET
      $MD
      Hospital/Nursing Management
      Health Care

    $MD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • EVP, GC, Chief Admin Off & Sec Moore Mary Ann E gifted 26,497 shares, decreasing direct ownership by 21% to 100,338 units (SEC Form 4)

      4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)

      3/7/25 5:00:10 PM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • EVP, CFO and Treasurer Rossi Kasandra H covered exercise/tax liability with 3,718 shares, decreasing direct ownership by 7% to 51,151 units (SEC Form 4)

      4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)

      3/4/25 5:00:09 PM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • EVP, GC, Chief Admin Off & Sec Moore Mary Ann E covered exercise/tax liability with 8,975 shares, decreasing direct ownership by 7% to 126,835 units (SEC Form 4)

      4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)

      3/4/25 5:00:17 PM ET
      $MD
      Hospital/Nursing Management
      Health Care

    $MD
    Financials

    Live finance-specific insights

    See more

    $MD
    Leadership Updates

    Live Leadership Updates

    See more

    $MD
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $MD
    SEC Filings

    See more
    • Pediatrix Medical Group Reports First Quarter Results

      Raises Full Year 2025 Adjusted EBITDA Outlook Range Pediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today reported earnings of $0.24 per share for the three months ended March 31, 2025. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.33. For the 2025 first quarter, Pediatrix reported the following results: Net revenue of $458 million; Net income of $21 million; and Adjusted EBITDA of $49 million. "Our strong first quarter results reflect same-unit top-line outperformance versus our expectations, continued steady cost management and the successful results of the portfolio restructuring we completed last year. As a result of our strong f

      5/6/25 6:00:00 AM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • Pediatrix Medical Group 2025 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 6, 2025

      Pediatrix Medical Group, Inc. (NYSE:MD) will host an investor conference call and webcast on Tuesday, May 6, 2025 at 9:00 a.m. ET to discuss results from operations for the quarter ended March 31, 2025. A detailed press release will be issued the morning of May 6, 2025 before the securities markets open. The investor conference call will be webcast and can be accessed at Pediatrix's website, www.pediatrix.com/investors. ABOUT PEDIATRIX MEDICAL GROUP Pediatrix® Medical Group, Inc. (NYSE:MD) is a leading provider of physician services. Pediatrix-affiliated clinicians are committed to providing coordinated, compassionate and clinically excellent services to women, babies and children across

      4/21/25 7:00:00 AM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • Pediatrix Medical Group Reports Fourth Quarter Results

      Pediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today reported earnings of $0.36 per share for the three months ended December 31, 2024. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.51. For the 2024 fourth quarter, Pediatrix reported the following results: Net revenue of $502 million; Net income of $30 million; and Adjusted EBITDA of $69 million. "Our strong fourth quarter results reflect continued top-line outperformance versus our expectations, the completion of our portfolio restructuring, and the related overhead expense reductions," said Mark S. Ordan, Chief Executive Officer of Pediatrix Medical Group. "I am honored and excited

      2/20/25 6:00:00 AM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • Pediatrix Announces Strategic Initiatives For Enhanced Shareholder Value Creation

      Executive Chair Mark S. Ordan to Return as Chief Executive Officer Company Redoubles Strategic Focus on Physician Practices and Hospital and Health System Relationships Pediatrix Medical Group, Inc. (NYSE:MD) ("Pediatrix" or "the Company"), a leading provider of physician services, today announced a leadership transition to accelerate its progress in executing a transformational strategy designed to create value for shareholders and other stakeholders. To best position Pediatrix to implement the strategy, which is based on recommitting to the highest standards in clinical excellence and strengthening the Company's hospital relationships, the Company's Board of Directors has appointed Ex

      1/13/25 6:00:00 AM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • Pediatrix Board Appoints Sylvia Young as Independent Director

      Pediatrix Medical Group, Inc. (NYSE:MD), the nation's leading provider of highly specialized health care for women, children and babies, today announced that its board of directors has appointed Sylvia Young, a recognized leader in healthcare and long-term healthcare executive, as an independent director, effective May 12, 2023. Ms. Young, a veteran of hospital administration since 1985, most recently served as President and CEO of the HCA Continental Division, a multi-state regional healthcare system that is part of Hospital Corporation of America (HCA). Prior to her appointment to the Denver-based Division headquarters, Ms. Young served as President of HCA's Sunrise Health System, inclu

      5/4/23 4:05:00 PM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • BurgerFi Appoints Vivian Lopez-Blanco to its Board of Directors

      PALM BEACH, Fla., July 15, 2021 (GLOBE NEWSWIRE) -- BurgerFi International, Inc. (NASDAQ:BFI, BFIIW))) ("BurgerFi" or the "Company"), one of the nation's fastest-growing premium fast-casual concepts, has appointed Vivian Lopez-Blanco to its board of directors, effective July 14, 2021. Lopez-Blanco's appointment follows the sudden passing of board member Steven Berrard announced on June 10, 2021. Lopez-Blanco has also been named as the chair of the audit committee and will be serving on the compensation committee and nominating governance committee. Lopez-Blanco is an experienced board member and seasoned finance executive with expertise in organizational transformations and driving prof

      7/15/21 7:30:00 AM ET
      $BFI
      $TAST
      $MD
      Restaurants
      Consumer Discretionary
      Hospital/Nursing Management
      Health Care
    • Pediatrix Medical Group Reports First Quarter Results

      Raises Full Year 2025 Adjusted EBITDA Outlook Range Pediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today reported earnings of $0.24 per share for the three months ended March 31, 2025. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.33. For the 2025 first quarter, Pediatrix reported the following results: Net revenue of $458 million; Net income of $21 million; and Adjusted EBITDA of $49 million. "Our strong first quarter results reflect same-unit top-line outperformance versus our expectations, continued steady cost management and the successful results of the portfolio restructuring we completed last year. As a result of our strong f

      5/6/25 6:00:00 AM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • Pediatrix Medical Group 2025 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 6, 2025

      Pediatrix Medical Group, Inc. (NYSE:MD) will host an investor conference call and webcast on Tuesday, May 6, 2025 at 9:00 a.m. ET to discuss results from operations for the quarter ended March 31, 2025. A detailed press release will be issued the morning of May 6, 2025 before the securities markets open. The investor conference call will be webcast and can be accessed at Pediatrix's website, www.pediatrix.com/investors. ABOUT PEDIATRIX MEDICAL GROUP Pediatrix® Medical Group, Inc. (NYSE:MD) is a leading provider of physician services. Pediatrix-affiliated clinicians are committed to providing coordinated, compassionate and clinically excellent services to women, babies and children across

      4/21/25 7:00:00 AM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • Pediatrix Medical Group Reports Fourth Quarter Results

      Pediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today reported earnings of $0.36 per share for the three months ended December 31, 2024. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.51. For the 2024 fourth quarter, Pediatrix reported the following results: Net revenue of $502 million; Net income of $30 million; and Adjusted EBITDA of $69 million. "Our strong fourth quarter results reflect continued top-line outperformance versus our expectations, the completion of our portfolio restructuring, and the related overhead expense reductions," said Mark S. Ordan, Chief Executive Officer of Pediatrix Medical Group. "I am honored and excited

      2/20/25 6:00:00 AM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • Pediatrix Medical Group Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - Pediatrix Medical Group, Inc. (0000893949) (Filer)

      5/8/25 4:30:14 PM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • SEC Form 10-Q filed by Pediatrix Medical Group Inc.

      10-Q - Pediatrix Medical Group, Inc. (0000893949) (Filer)

      5/6/25 7:00:19 AM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • Pediatrix Medical Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Pediatrix Medical Group, Inc. (0000893949) (Filer)

      5/6/25 6:50:08 AM ET
      $MD
      Hospital/Nursing Management
      Health Care